Silence Therapeutics plc (SLN) NASDAQ
6.37
-0.16(-2.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 287.17M |
| Enterprise Value | 276.05M |
| P/E Ratio | -3.53 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 326.51 |
| Price/Book Ratio | 6.09 |
| Enterprise/Revenue | 320.52 |
| Enterprise/EBITDA | -3.74 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -92.43 |
| Operating Margin | -93.97 |
Management Effectiveness
| Return On Assets | -0.74 |
| Return On Equity | -1.22 |
Income Statement
| Revenue | 559,000 |
| Revenue/Share | 0.02 |
| Gross Profit | 344,000 |
| EBITDA | -89.2M |
| Net Income | -88.61M |
| Diluted EPS | -1.89 |
Balance Sheet
| Total Cash | 70.08M |
| Total Cash/Share | 1.48 |
| Total Debt | 135,999 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.83 |
| Book Value Per Share | 1.05 |
Price History
| 52-Week Change | 11.17 |
| 52-Week High | 8.4 |
| 52-Week Low | 4.19 |
| Moving Average 50 Days | 6.57 |
| Moving Average 200 Days | 6.01 |
Statistics
| Average Volume | 334,147 |
| Shares Outstanding | 47.23M |
| % Held by Institutions | 42.15 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
